Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents

Por Ayoub, Nehad M, Al-Shami, Kamal M, Alqudah, Mohammad A, Mhaidat, Nizar M
Publicado no Onco Targets Ther (2017)

Enhancing Diagnosis, Prognosis, and Therapeutic Outcome Prediction of Gliomas Using Genomics

Por Assem, Mahfoud, Sibenaller, Zita, Agarwal, Supreet, Al-Keilani, Maha S., Alqudah, Mohammad A.Y., Ryken, Timothy C.
Publicado em 2012

Tumor Derived Mutations of Protein Tyrosine Phosphatase Receptor Type K Affect Its Function and Alter Sensitivity to Chemotherapeutics in Glioma

Por Agarwal, Supreet, Al-Keilani, Maha S., Alqudah, Mohammad A. Y., Sibenaller, Zita A., Ryken, Timothy C., Assem, Mahfoud
Publicado em 2013

NOTCH3 Is a Prognostic Factor That Promotes Glioma Cell Proliferation, Migration and Invasion via Activation of CCND1 and EGFR

Por Alqudah, Mohammad A. Y., Agarwal, Supreet, Al-Keilani, Maha S., Sibenaller, Zita A., Ryken, Timothy C., Assem, Mahfoud
Publicado em 2013